VERVE THERAPEUTICS INC's ticker is VERV and the CUSIP is 92539P101. A total of 101 filers reported holding VERVE THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.05 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $113 | -15.7% | 8,544 | +18.8% | 0.00% | -33.3% |
| Q2 2023 | $134 | +54.0% | 7,194 | +18.9% | 0.00% | +50.0% |
| Q1 2023 | $87 | -19.4% | 6,050 | +7.8% | 0.00% | 0.0% |
| Q4 2022 | $108 | -100.0% | 5,610 | -59.1% | 0.00% | -84.6% |
| Q3 2022 | $471,000 | +970.5% | 13,719 | +373.1% | 0.01% | +1200.0% |
| Q2 2022 | $44,000 | -4.3% | 2,900 | +42.2% | 0.00% | 0.0% |
| Q1 2022 | $46,000 | – | 2,040 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alphabet Inc. | 10,974,011 | $167,683,000 | 9.10% |
| ARCH Venture Management, LLC | 2,508,809 | $38,335,000 | 4.67% |
| Casdin Capital, LLC | 3,138,167 | $47,951,000 | 4.05% |
| M28 Capital Management LP | 178,500 | $2,727,000 | 3.06% |
| Redmile Group, LLC | 1,833,547 | $28,017,000 | 1.07% |
| Cormorant Asset Management, LP | 700,710 | $10,707,000 | 0.81% |
| Novo Holdings A/S | 927,100 | $14,166,000 | 0.70% |
| Pinz Capital Management, LP | 51,800 | $792,000 | 0.54% |
| PFM Health Sciences, LP | 845,186 | $12,914,000 | 0.49% |
| Artal Group S.A. | 400,000 | $6,112,000 | 0.33% |